Statistics from Altmetric.com
Study design: randomised, single-blind trial.
Setting: The Netherlands.1
Patients: 94 patients with new-onset (symptom duration <18 months) juvenile idiopathic arthritis (JIA) who had not been exposed to previous disease-modifying antirheumatic drug (DMARD) therapy.
Interventions: conventional systemic DMARD monotherapy (methotrexate (MTX) or sulfasalazine) versus MTX plus 6-week tapered course of prednisolone vs MTX plus etarnercept.
Outcomes: time to inactive disease; time to flare after the first episode of drug-free inactive disease (DFID).
Main results: …
Contributors LC: wrote the abstract. AJF and LC: jointly wrote the commentary.
Provenance and peer review Not commissioned; internally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.